Stock LSTA LISATA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lisata Therapeutics, Inc.

Equities

LSTA

US1280583022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
2.75 USD -0.72% Intraday chart for Lisata Therapeutics, Inc. +0.73% +0.73%
Apr. 23 Lisata Therapeutics, Qilu Pharmaceutical Dose First Patient in China Trial of LSTA1 Plus Chemo for Pancreatic Cancer MT
Apr. 23 Lisata Therapeutics, Inc and Qilu Pharmaceutical Co., Ltd Announce First Patient Treated in Qilu?s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LISATA THERAPEUTICS, INC. Stock Lisata Therapeutics, Inc.
 22.85M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 46.4B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.75B
LONZA GROUP AG Stock Lonza Group AG
 41.37B
CELLTRION, INC. Stock Celltrion, Inc.
 29.71B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.01B
  1. Stock Market
  2. Equities
  3. LSTA Stock
  4. Charts Lisata Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW